Inventor
JONES FRANK R
US39 patents
⚠️ This page may combine multiple inventors who share the name “JONES FRANK R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ETUBICS CORP
17 patentsUS10695417B2Jun 30, 2020
Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
ETUBICS CORP9 citations83
US10563224B2Feb 18, 2020
Replication defective adenovirus vector in vaccination
ETUBICS CORP5 citations83
US11389521B2Jul 19, 2022
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP3 citations82
US11376316B2Jul 5, 2022
Breast cancer vaccines and methods of use thereof
ETUBICS CORP3 citations82
US11369673B2Jun 28, 2022
HPV vaccines and methods of use thereof
ETUBICS CORP3 citations82
US11344613B2May 31, 2022
Sequential administration of a replication defective adenovirus vector in vaccination protocols
ETUBICS CORP3 citations82
US11104916B2Aug 31, 2021
Compositions and methods for alphavirus vaccination
ETUBICS CORP6 citations82
US11826417B2Nov 28, 2023
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP1 citations71
US11529408B2Dec 20, 2022
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP1 citations71
US11504423B2Nov 22, 2022
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP2 citations71
US11149087B2Oct 19, 2021
Methods and compositions for combination immunotherapy
ETUBICS CORP2 citations71
US10835596B2Nov 17, 2020
Compositions and methods for flavivirus vaccination
ETUBICS CORP2 citations71
US12370250B2Jul 29, 2025
Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
ETUBICS CORP0 citations61
US11352642B2Jun 7, 2022
Methods and compositions for combination immunotherapy
ETUBICS CORP1 citations61
US11304998B2Apr 19, 2022
Combination immunotherapies comprising IL-15 superagonists
ETUBICS CORP1 citations60
US11116827B2Sep 14, 2021
Compositions and methods for tumor vaccination and immunotherapy involving HER antigens
ETUBICS CORP1 citations60
US11020467B2Jun 1, 2021
Combination immunotherapies comprising IL-15 superagonists
ETUBICS CORP1 citations60
BASF CORP
11 patentsUS5236645AAug 17, 1993
Addition of additives to polymeric materials
BASF CORP80 citations96
US5834089ANov 10, 1998
Additive-containing synthetic filaments, and yarns and carpets including such filaments
BASF CORP55 citations95
US6232371B1May 15, 2001
Dispersible additive systems for polymeric materials, and methods of making and incorporating the same in such polymeric materials
BASF CORP16 citations91
US5800746ASep 1, 1998
Methods of making pigmented synthetic filaments
BASF CORP17 citations91
US5955516ASep 21, 1999
Methods of making dispersible additives for polymeric materials
BASF CORP10 citations81
US5889089AMar 30, 1999
Additive-containing polymeric compositions and methods of making the same
BASF CORP10 citations81
US5869551AFeb 9, 1999
Dispersible additive systems for polymeric materials
BASF CORP11 citations81
US5833893ANov 10, 1998
Methods of making different additive-containing filaments
BASF CORP16 citations81
US5973032AOct 26, 1999
Dispersible additive systems for polymeric materials
BASF CORP3 citations73
US6416859B1Jul 9, 2002
Methods of making pigmented filaments
BASF CORP8 citations72
US7019050B2Mar 28, 2006
Alternate dispersants for spray-dried concentrate components
BASF CORP0 citations52
IMRE CORP
4 patentsUS5122112AJun 16, 1992
Antigen-specific removal of circulating immune complexes
IMRE CORP42 citations92
US5037649AAug 6, 1991
Method for treatment of HIV-infected patients
IMRE CORP35 citations91
US4865841ASep 12, 1989
Methods and compositions for transient elimination of humoral immune antibodies
IMRE CORP29 citations87
US4801449AJan 31, 1989
Method for treatment of Kaposi's sarcoma
IMRE CORP23 citations81